lymphoid malignancy Flashcards

1
Q

lymphoma

A
lymphoid origin
can present with enlarged lymph nodes (lymphadenopathy)
or
extranodal involvement
or 
bone marrow involvement
systemic B symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diagnosis

A

biopsy tells us what type
clinical exam and imaging tells staging
-info of prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

therapy

A

never surgical resection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hodgkin lymphoma

A

specific disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

non hodgkin

A

broad term/everything else

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lymphoproliferative disorders

A
ALL
CLL
Hodgkin
Non-hodgkin
- high grade (difffuse large B cell lymphoma)
- low grade (follicular, marginal zone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ALL

A

disorder of lymphoid progenitor cells
Leukaemia = No differentiation. Instead, rapid, uncontrolled growth and accumulation
Usually in bone marrow but they can go anywhere
-75-90% in children under 6
B cell lineage mostly affected
present with 2-3 week of bone marrow failure or bone/joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

typical ALL case

A
17yr old male
1 month impaired vision(both eyes)
half stone weight loss
breathless on minimal exertion
hb and platelets low
white cell very high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics

A

large cells
express CD19- all B cells
CD34,TDT-markers of very early immature cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

treatment

A
standard
-induction chemotherapy to obtain remission
-consolidation therapy
-CNS directed treatment
-maintenance treatment for 18 months
transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALL treatment

A

Newer therapies

1) Bi specific T cell engagers?
2) Chimeric antigen receptor T cells
- Healthy T cells harvested
- transfected to express a specific T cell receptor expressed on leukemia cells (CD19)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T cell immunotherapy side effects

not in exam

A

Cytokine release syndrome -fever, hypotension, dyspnoea
neurotoxicity- confusion
seizure, headache, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Poor risk factors ALL

A
increasing age
white count
cytogenetics
t(9,22); t(4,11)
poor response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

summary ALL

A

bone marrow failure +/- raised white cell count
Bone pain, infection, sweats
Treated with multiagent intensive chemo +/- allogeneic stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CLL

A

the abnormal cells are mature – they usually resemble normal, well-behaved lymphocytes
Grow slowly (or not at all)
Classic example of a low-grade condition
Carry many of the normal markers that B lymphocytes have

Requires a lymphocyte count of > 5 (normal is < 4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CLL continued

A
Commonest leukemia
occasionally familial
2 makes: 1 female
often asymptomatic
-bone marrow failure
-lymphadenopathy
-splenomegaly 
fever and sweats
Less common findings:
hepatomegaly
infections weight loss
17
Q

associated findings

A
immune paresis (loss of Ig production)
Haemolytic anaemia
18
Q

CLL staging

A
Stage A
<3 lymph nodes
median survival same as age matched controls
stage B 3 or more lymph nodes
Stage C
Stage B- anaemia or thrombocytopenia
19
Q

indications for treatment

A
Progressive bone marrow failure
Massive lymphadenopathy 
Progressive splenomegaly
Lymphocyte doubling time <6 months or >50% increase over 2 months
Systemic symptoms
Autoimmune cytopenias
20
Q

treatment

A
incurable
low grade
watch and wait
cytotoxic chemotherapy
monoclonal antibodies
eg Rituximab
novel agents
21
Q

poor prognostic marker

A
Advanced disease (Binet stage B or C)
Atypical lymphocyte morphology
Rapid lymphocyte doubling time (<12 mth)
CD 38+ expression
Loss/mutation p53; del 11q23 (ATM gene)
Unmutated IgVH gene status
22
Q

what is an adverse prognostic factor

A

loss/mutation of P53

23
Q

ann arbour staging system

A

I-IV

24
Q

B cells

A

majority of leukemias

25
Q

high grade lymphoma

A

Aggressive, fast-growing
Require combination chemotherapy
Can be cured

26
Q

low grade

A

Indolent, often asymptomatic

responds to chemotherapy but incurable

27
Q

non hodgkin lymphoma

A

Diffuse large B-cell lymphoma
Commonest subtype of lymphoma (of any kind)
High-grade lymphoma
Follicular lymphoma
2nd commonest subtype of lymphoma
Low-grade lymphoma
Like CLL, leave alone if not causing problems – “watch and wait”
Both are treated with combination chemotherapy – typically anti-CD20 monoclonal antibody + chemo

28
Q

hodgkin lymphoma

A

30% of all lymphomas
-association with epstein barr virus; familial and geographical clustering

Treatment (dont need to know)
Combination chemotherapy (ABVD)
\+/- radiotherapy
Monoclonal antibodies (anti-CD30)
Immunotherapy (checkpoint inhibitors)
1st peak at 15-35y (not associated to virus)
2nd peak later in life

PET scanning central to assessment of response to treatment
associated to immunity to fight viruses

29
Q

features

A

hodgkin lymphoma

contiguos lymph nodes